Clinical trial
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating…
NCT00354419 · Fred Hutchinson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00354419 |
|---|---|
| Title | Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant |
| Official title | A Dose Finding Study of Total Body Irradiation for Conditioning Patients With Severe Aplastic Anemia Transplanted With Umbilical Cord Blood |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Biological, Drug, Genetic, Procedure, Radiation |
| Interventions | total-body irradiation, cyclophosphamide, anti-thymocyte globulin, cyclosporine, umbilical cord blood transplantation, mycophenolate mofetil, bone marrow aspiration, DNA analysis, filgrastim |
| Enrollment | 30 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2010 |
| First posted | Jul 20, 2006 |
| Last update posted | Jan 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: